Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Current Leases (2016)

Historic Current Leases for Viridian Therapeutics, Inc.\DE (VRDN) over the last 3 years, with Q4 2016 value amounting to $4000.0.

  • Viridian Therapeutics, Inc.\DE's Current Leases fell 9545.45% to $4000.0 in Q4 2016 from the same period last year, while for Dec 2016 it was $4000.0, marking a year-over-year decrease of 9545.45%. This contributed to the annual value of $4000.0 for FY2016, which is 9545.45% down from last year.
  • Viridian Therapeutics, Inc.\DE's Current Leases amounted to $4000.0 in Q4 2016, which was down 9545.45% from $88000.0 recorded in Q4 2015.
  • Viridian Therapeutics, Inc.\DE's Current Leases' 5-year high stood at $88000.0 during Q4 2015, with a 5-year trough of $4000.0 in Q4 2016.
  • For the 3-year period, Viridian Therapeutics, Inc.\DE's Current Leases averaged around $57333.3, with its median value being $80000.0 (2014).
  • Its Current Leases has fluctuated over the past 5 years, first skyrocketed by 1000.0% in 2015, then crashed by 9545.45% in 2016.
  • Over the past 3 years, Viridian Therapeutics, Inc.\DE's Current Leases (Quarter) stood at $80000.0 in 2014, then rose by 10.0% to $88000.0 in 2015, then crashed by 95.45% to $4000.0 in 2016.
  • Its Current Leases was $4000.0 in Q4 2016, compared to $88000.0 in Q4 2015 and $80000.0 in Q4 2014.